MWNA
MYOV

Marshall Wace North America’s Myovant Sciences Ltd. MYOV Stock Holding History

Marshall Wace North America’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-192,994
Closed -$4.39M – 1816
2021
Q2 		$4.39M Buy
+192,994
New +$4.06M 0.02% 586
2020
Q3 		– Sell
-110,497
Closed -$2.28M – 1557
2020
Q2 		$2.28M Buy
110,497
+65,398
+145% +$890K 0.02% 557
2020
Q1 		$341K Buy
+45,099
New +$506K ﹤0.01% 831
2019
Q4 		– Sell
-49,857
Closed -$259K – 1699
2019
Q3 		$259K Buy
+49,857
New +$370K ﹤0.01% 914

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace North America's MYOV Position: Q3 2021 in Review

Marshall Wace North America sold out of Myovant Sciences Ltd. (MYOV) in Q3 2021, closing a stake of 192,994 shares — an estimated $4.39M sold.

Marshall Wace North America first reported a position in MYOV in Q3 2019 and held it in 4 quarters. The position peaked at $4.39M in Q2 2021. 105 funds tracked by Wall St. Rank hold MYOV as of Q3 2021.

  • Marshall Wace North America reported no remaining Myovant Sciences Ltd. position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace North America sold 192,994 Myovant Sciences Ltd. shares in Q3 2021, an estimated $4.39M.
  • Marshall Wace North America first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 4 quarters.
  • Marshall Wace North America's Myovant Sciences Ltd. position peaked at $4.39M in Q2 2021.
  • 105 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.